Massachusetts, US-based life sciences company MilliporeSigma has acquired Germany based mRNA contract development and manufacturing organisation AmpTec, to expand mRNA capabilities for vaccines, treatments and diagnostics, the company said.
Financial terms were not disclosed.
The deal strengthens MilliporeSigma's capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments and diagnostics applicable in Covid-19 and many other diseases.
The acquisition of AmpTec adds to MilliporeSigma's lipid manufacturing expertise, providing an integrated offering across mRNA value chain.
Ardian Closes Acquisition of Audit and Spend Analytics Services Provider PRGX
Merck Launches Tender Offer to Acquire Pandion Therapeutics
Plex Systems Acquires Kors Engineering to Expand Manufacturing Process Automation
asTech Acquires adasThink to Expand Diagnostics and Service Offerings
SpinTech Acquires MR Innovations to Extend R and D in Medical Imaging
Healthcare Bluebook Acquires Quantros´ Quality Division to Enhance Analytics Capabilities
IDS International Acquires DECO and GovSource to Strengthen Multidisciplinary Training Services
Buildertrend Acquires CoConstruct to Expand Position in Construction Management Platform
Altair Acquires Flow Simulator from GE Aviation to Form Long-Term Partnership
Clubessential Holdings Acquires foreUP to Expand Presence to Public Golf Clubs and Courses